| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 39.39 | 0.1% |
| Total Income | 39.39 | 0.1% |
| Expenditure | 41.19 | 0.6% |
| PBT | -2.86 | 10.9% |
| Net Profit | -2.40 | 15.8% |
| OPM | -4.58% | 0.54pp |
| NPM | -6.08% | 1.15pp |
| EPS | -0.03 | 40.0% |
AirSculpt Technologies Reports Q1 2026 Results; Same Center Sales Increase 1%
08 May 2026 · 8 May, 4:11 pm
Summary
AirSculpt Technologies reported flat revenue of $39.4 million for Q1 2026, with a 1% increase in same center sales. The net loss improved to $2.4 million from $2.8 million in the prior year's quarter. Adjusted EBITDA was $3.3 million, down from $3.8 million in Q1 2025. The company reaffirmed its full year 2026 revenue guidance of $151 to $157 million and adjusted EBITDA guidance of $15 to $17 million.
Key Highlights
- 1
AirSculpt Technologies reported flat revenue at $39.4 million for the first quarter of 2026 compared to the first quarter of 2025.
- 2
Same center sales increased by 1% in the first quarter of 2026.
- 3
The company's net loss for the quarter was $2.4 million, an improvement from the $2.8 million net loss in the first quarter of 2025.
- 4
Adjusted EBITDA for the first quarter of 2026 was $3.3 million, compared to $3.8 million in the first quarter of 2025.
- 5
Case volume increased slightly by 0.2% to 3,082 in the first quarter of 2026 from 3,076 in the first quarter of 2025.
- 6
The company reaffirmed its full year 2026 revenue guidance of approximately $151 to $157 million.
- 7
AirSculpt reaffirmed its full year 2026 adjusted EBITDA guidance of approximately $15 to $17 million.
Management Comments
Yogi Jashnani
We had a solid start to the year delivering stabilization in revenue, positive same center sales, and a strengthened balance sheet in the first quarter. Our performance marks a key turning point for AirSculpt - the culmination of our transformational work in 2025 has given us a durable business model and a solid foundation to advance our strategy to achieve sustained long term profitable growth. I am proud of our team and confident in our ability to continue our favorable momentum as reflected in our reaffirmation of 2026 guidance. Same center sales continue to build as we enter our seasonally strong second quarter fueled by our enhanced and elevated sales and marketing initiatives. We move forward with the right talent, business model, strategy and balance sheet to maximize the power of our AirSculpt brand and proven body contouring procedures while broadening our reach, adding new incremental surgeries that leverage our operating platform and more fully capitalize on our GLP-1 opportunity. We believe that fiscal 2026 will include significant progress toward our goals of consistent revenue and profit growth and shareholder value creation
Informational and educational content only. Not investment advice.